Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Getting Vyondys 53 (Golodirsen) Covered by Blue Cross Blue Shield in Ohio: ICD-10, HCPCS J-Code, and Prior Authorization Guide

Answer Box: Getting Vyondys 53 Covered in Ohio Vyondys 53 (golodirsen) requires prior authorization from Blue Cross Blue Shield Ohio through their NovoLogix portal. You'll need genetic confirmation of DMD with exon 53-skippable mutation (ICD-10: G71.01), proper billing codes (HCPCS J1429, NDC 60923-0465), and clinical documentation. Submit

Coding That Helps Get Advate (octocog alfa) Approved by Blue Cross Blue Shield in Washington (ICD-10, HCPCS, NDC Guide)

Quick Answer: Getting Advate Covered in Washington Blue Cross Blue Shield of Washington requires prior authorization for Advate (octocog alfa) using specific medical codes. Use ICD-10 code D66 (hereditary factor VIII deficiency), HCPCS J7192 (factor VIII recombinant, per IU), and the product NDC. Submit via Premera's Availity portal

How to Get Uplizna (Inebilizumab) Covered by Blue Cross Blue Shield of Illinois: Complete Guide to Prior Authorization, Appeals, and State Protections

Answer Box: Getting Uplizna Covered by BCBS Illinois Blue Cross Blue Shield of Illinois (BCBSIL) requires prior authorization for Uplizna (inebilizumab), but Illinois' strong patient protection laws help secure coverage. For AQP4-positive NMOSD or IgG4-related disease, follow these steps: 1. Submit prior authorization through BCBSIL's provider portal

How to Get Oxervate (Cenegermin) Covered by Blue Cross Blue Shield in Florida: Complete Prior Authorization Guide

Answer Box: Getting Oxervate Approved by Florida Blue Florida Blue requires prior authorization (PA) for Oxervate (cenegermin) with specific criteria: confirmed stage 2 or 3 neurotrophic keratitis, documented failure of preservative-free artificial tears for ≥2 weeks, and corneal sensitivity testing results. Submit PA via Availity.com or call 1-877-719-2583. First

How to Get Elzonris (tagraxofusp-erzs) Covered by Blue Cross Blue Shield in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Elzonris Covered in New York Elzonris (tagraxofusp-erzs) requires prior authorization from Blue Cross Blue Shield for BPDCN treatment. New York patients need: confirmed BPDCN diagnosis with CD123-positive pathology, serum albumin ≥3.2 g/dL, and a capillary leak syndrome monitoring plan. If denied, you have 4 months

How to Get Amondys 45 (Casimersen) Covered by Blue Cross Blue Shield in Ohio: Complete Prior Authorization Guide

Answer Box: Getting Amondys 45 Covered by Blue Cross Blue Shield in Ohio Blue Cross Blue Shield Ohio (Anthem) requires prior authorization for Amondys 45 (casimersen) for DMD patients with confirmed exon 45 skipping-amenable mutations. Submit form CC-0189 via Availity.com with genetic testing, 6-minute walk test results, and specialist

How to Get Amondys 45 (Casimersen) Covered by Blue Cross Blue Shield Michigan: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Amondys 45 Covered in Michigan Blue Cross Blue Shield of Michigan (BCBSM) currently considers Amondys 45 (casimersen) investigational/experimental, requiring prior authorization that's typically denied. However, Michigan patients have strong appeal rights through DIFS external review. Fastest path to approval: 1. Submit prior authorization with

Do You Qualify for Voydeya (danicopan) Coverage by Blue Cross Blue Shield in New York? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Voydeya Coverage If you have paroxysmal nocturnal hemoglobinuria (PNH) with extravascular hemolysis despite C5 inhibitor therapy, you likely qualify for Voydeya (danicopan) coverage through Blue Cross Blue Shield in New York. The fastest approval path requires: (1) Current C5 inhibitor therapy (Soliris/Ultomiris), (2)

How to Get Givlaari (Givosiran) Covered by Florida Blue Cross Blue Shield: Complete Forms, Appeals, and Approval Guide

Quick Answer: Getting Givlaari Covered by Florida Blue in 2024 Florida Blue requires prior authorization for Givlaari (givosiran) with specific medical criteria. Submit your request through Availity.com or call 1-877-719-2583. You'll need confirmed acute hepatic porphyria diagnosis with elevated PBG/ALA levels, genetic testing, and documented attack

How to Get Xenpozyme (olipudase alfa-rpcp) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Coding, Appeals, and Authorization Guide

Answer Box: Getting Xenpozyme Covered in Pennsylvania Xenpozyme (olipudase alfa-rpcp) requires prior authorization from Blue Cross Blue Shield plans in Pennsylvania. Use ICD-10 codes E75.240 (type A), E75.241 (type B), or E75.244 (type A/B) for ASMD diagnosis. Submit PA with genetic confirmation, baseline organ assessments, and